Structures by: Ganin E. V.
Total: 54
3-[(4-nitrophenyl)imino]-1H,3H-benzo[de]isochromen-1-one
C18H10N2O4
The Journal of Physical Chemistry C (2013) 117, 35 18154
a=29.360(3)Å b=3.8228(3)Å c=24.968(2)Å
α=90.00° β=93.109(10)° γ=90.00°
1,4,7,10,13-pentaoxacyclopentadecane ethanedithioamide clathrate
C10H20O5,C2H4N2S2
Organic & Biomolecular Chemistry (2003) 1, 16 2922
a=8.2660(5)Å b=8.6440(6)Å c=12.5320(10)Å
α=80.053(3)° β=81.737(3)° γ=75.392(3)°
1,4,7,10,13,16-hexaoxacyclooctadecane N,N'- (thiocarbamoyl)hydrazine clathrate
C12H24O6,C2H6N4S2
Organic & Biomolecular Chemistry (2003) 1, 16 2922
a=14.196(3)Å b=7.187(2)Å c=19.552(3)Å
α=90.00° β=92.18(2)° γ=90.00°
Cis-anti-cis (B) isomer (2,3,11,12-dicyclohexano- 1,4,7,10,13,16-hexaoxacyclooctadecane bis(ethanedithioamide) clathrate
C20H36O6,2(C2H4N2S2)
Organic & Biomolecular Chemistry (2003) 1, 16 2922
a=12.654(3)Å b=7.5700(15)Å c=17.129(3)Å
α=90.00° β=106.14(3)° γ=90.00°
Cis-anti-cis isomer (B) (2,3,11,12-dicyclohexano- 1,4,7,10,13,16-hexaoxacyclooctadecane N,N'-(thiocarbamoyl)hydrazine clathrate
C20H36O6,C2H6N4S2
Organic & Biomolecular Chemistry (2003) 1, 16 2922
a=12.489(2)Å b=7.509(2)Å c=14.639(3)Å
α=90.00° β=93.61(3)° γ=90.00°
1,4,7,10,13-pentaoxacyclopentadecane bis(N,N'- (thiocarbamoyl)hydrazine) clathrate
C10H20O5,2(C2H6N4S2)
Organic & Biomolecular Chemistry (2003) 1, 16 2922
a=13.632(3)Å b=9.475(2)Å c=19.185(4)Å
α=90.00° β=90.00° γ=90.00°
1,4,7,10-tetraoxacyclododecane N,N'-(thiocarbamoyl)hydrazine clathrate
C8H16O4,C2H6N4S2
Organic & Biomolecular Chemistry (2003) 1, 16 2922
a=18.475(4)Å b=18.445(4)Å c=9.443(2)Å
α=90.00° β=90.00(3)° γ=90.00°
1,4,7,10,13,16-hexaoxacyclooctadecane pyrimidine-2,4(1H,3H)- dithione monohydrate
C12H24O6,C4H4N2S2,H2O
Organic & biomolecular chemistry (2005) 3, 16 3054-3058
a=7.7070(15)Å b=17.374(4)Å c=16.622(3)Å
α=90.00° β=92.17(3)° γ=90.00°
2,3-benzo-1,4,7,10,13,16-hexaoxacyclooctadeca-2-ene pyrimidine-2,4(1H,3H)-dithione monohydrate
C16H24O6,C4H4N2S2,H2O
Organic & biomolecular chemistry (2005) 3, 16 3054-3058
a=7.9730(16)Å b=16.918(3)Å c=17.566(4)Å
α=90.00° β=90.00° γ=90.00°
Cis-anti-cis (B) isomer (2,3,11,12-Dicyclohexano- 1,4,7,10,13,16-hexaoxacyclooctadecane) bis(pyrimidine-2,4(1H,3H)- dithione) clathrate
C20H36O6,2(C4H4N2S2)
Organic & biomolecular chemistry (2005) 3, 16 3054-3058
a=11.624(2)Å b=12.698(3)Å c=12.093(2)Å
α=90.00° β=109.69(3)° γ=90.00°
Cis-syn-cis (A) isomer (2,3,11,12-Dicyclohexano- 1,4,7,10,13,16-hexaoxacyclooctadecane) pyrimidine-2,4(1H,3H)-dithione monohydrate
C20H36O6,C4H4N2S2,H2O
Organic & biomolecular chemistry (2005) 3, 16 3054-3058
a=7.9880(16)Å b=21.627(4)Å c=16.439(3)Å
α=90.00° β=93.17(3)° γ=90.00°
1,7-dioxa-4,10-diazoniacyclododecane bis(4-aminobenzoate) dihydrate
C8H20N2O2,2(C7H6NO2),2(H2O)
New Journal of Chemistry (2007) 31, 4 561
a=10.9044(14)Å b=9.9475(13)Å c=12.1429(15)Å
α=90.00° β=114.267(2)° γ=90.00°
4,10-diaza-1,7-diazoniacyclododecane bis(4-aminobenzoate) dihydrate
C8H22N4,2(C7H6NO2),2(H2O)
New Journal of Chemistry (2007) 31, 4 561
a=9.6004(19)Å b=11.350(2)Å c=12.088(2)Å
α=90.00° β=111.91(3)° γ=90.00°
1,4,7,10,13-pentaoxa-16-azoniacyclooctadecane 4-aminobenzoate trihydrate
C12H26NO5,C7H6NO2,3(H2O)
New Journal of Chemistry (2007) 31, 4 561
a=24.784(4)Å b=9.6757(17)Å c=10.0867(18)Å
α=90.00° β=90.00° γ=90.00°
Piperazinediium bis(4-aminobenzoate) dihydrate
C4H12N2,2(C7H6NO2),2(H2O)
New Journal of Chemistry (2007) 31, 4 561
a=6.5739(13)Å b=11.597(2)Å c=12.604(3)Å
α=90.00° β=90.13(3)° γ=90.00°
Meso-(5S,12S)-5,7,7,12,14,14-hexamethyl-4,11-diaza-1,8- diazoniacyclotetradecane bis(4-aminobenzoate) hydrate
C16H38N4,2(C7H6NO2),H2O
New Journal of Chemistry (2007) 31, 4 561
a=19.0506(13)Å b=12.1200(9)Å c=14.4397(10)Å
α=90.00° β=107.7200(10)° γ=90.00°
7,16-bis(4-methoxybenzyl)-1,4,10,13-tetraoxa-7,16- diazoniacyclooctadecane dihexafluorotantalate dihydrate
C28H44N2O6,2(TaF6),2(H2O)
New Journal of Chemistry (2009) 33, 8 1646
a=6.8062(11)Å b=11.3381(18)Å c=14.098(2)Å
α=105.873(9)° β=101.336(9)° γ=106.175(6)°
2,3,5,6,8,9,11,12-octahydro-thieno(3,4-b)-1,4,7,10,13- pentaoxacyclopentadecyne
C12H18O5S
CrystEngComm (2011) 13, 2 674
a=16.674(3)Å b=8.545(2)Å c=19.279(4)Å
α=90.00° β=90.00° γ=90.00°
2,3,5,6,8,9,11,12-octahydronaphtho(2,3-b) (1,4,7,10,13)pentaoxacyclopentadecine 1,2,5-oxadiazole-3,4-diamine monohydrate
C18H22O5,C2H4N4O,H2O
CrystEngComm (2011) 13, 2 674
a=10.536(2)Å b=15.585(4)Å c=13.639(3)Å
α=90.00° β=91.17(2)° γ=90.00°
2,3,5,6,8,9,11,12-octahydronaphtho(2,3-b)(1,4,7,10,13) pentaoxacyclopentadecine 3-nitro-1H-1,2,4-triazole clathrate
C18H22O5,C2H2N4O2
CrystEngComm (2011) 13, 2 674
a=7.219(1)Å b=10.992(2)Å c=13.356(3)Å
α=89.43(2)° β=78.84(2)° γ=80.80(2)°
18,18'-(E)-ethene-1,2-diylbis-2,3,5,6,8,9,11,12,14,15- decahydro-1,4,7,10,13,16-benzohexaoxacyclooctadecine bis(ethanedithioamide) clathrate
C34H48O12,2(C2H4N2S2)
CrystEngComm (2011) 13, 2 674
a=7.7140(15)Å b=9.760(2)Å c=15.675(3)Å
α=90.12(2)° β=96.87(3)° γ=107.23(3)°
2,3,5,6,8,9,11,12-octahydro-thieno(3,4-b)-1,4,7,10,13- pentaoxacyclopentadecyne ethanebis(thioamide)
C12H18O5S,C2H4N2S2
CrystEngComm (2011) 13, 2 674
a=9.945(2)Å b=15.102(3)Å c=12.647(2)Å
α=90.00° β=91.68(2)° γ=90.00°
2,3,5,6,8,9,11,12-octahydronaphtho(2,3-b)(1,4,7,10,13) pentaoxacyclopentadecine ethanebis(thioamide) clathrate
C18H22O5,C2H4N2S2
CrystEngComm (2011) 13, 2 674
a=7.965(2)Å b=10.521(2)Å c=13.080(3)Å
α=90.00° β=93.68(2)° γ=90.00°
Bis(triphenylmethanol) 1,4,7,10-tetraoxacyclooctadecane clathrate
2(C19H16O),C8H16O4
CrystEngComm (2009) 11, 1 94
a=8.3614(7)Å b=10.4963(9)Å c=11.7100(10)Å
α=82.114(2)° β=86.716(2)° γ=66.740(2)°
Triphenylmethanaminium trifluoroacetate 2-methoxyethanol clathrate
C19H18N,C3H8O2,C2F3O2
CrystEngComm (2009) 11, 1 94
a=17.069(4)Å b=10.694(3)Å c=26.520(7)Å
α=90.00° β=107.367(5)° γ=90.00°
Bis(3-(hydroxy(diphenyl)methyl)benzenesulfonamide) 1,4,7,10,13,16-hexaoxacyclooctadecane clathrate
2(C19H17NO3S),C12H24O6
CrystEngComm (2009) 11, 1 94
a=8.4707(6)Å b=12.4699(9)Å c=12.8600(9)Å
α=115.3720(10)° β=97.9290(10)° γ=99.5400(10)°
Bis (triphenylmethanaminium thiocyanate) 1,4,7,10- tetraoxacyclododecane clathrate
2(C19H18N,NCS),C8H16O4
CrystEngComm (2009) 11, 1 94
a=14.7301(15)Å b=16.1984(16)Å c=9.7290(10)Å
α=90.00° β=103.973(2)° γ=90.00°
Bis(1,1,1-triphenylmethanamine) 1,4,7,10-teraoxacyclododecane clathrate
2(C19H17N),C8H16O4
CrystEngComm (2009) 11, 1 94
a=8.4675(8)Å b=10.2973(13)Å c=11.943(2)Å
α=84.058(9)° β=88.008(12)° γ=67.966(8)°
Tetrabenzylcyclen
C36H44N4
CrystEngComm (2011) 13, 11 3682
a=15.285(3)Å b=6.4670(10)Å c=16.654(2)Å
α=90.00° β=110.64(3)° γ=90.00°
1,4,7,10-tetrabenzyl-1,4,7,-triazonia-10-azacyclododecane fluoride hexafluorosilicate tetrahydrate
C36H47N4,F,SiF6,4(H2O)
CrystEngComm (2011) 13, 11 3682
a=37.0414(14)Å b=11.1521(4)Å c=19.2636(7)Å
α=90.00° β=100.044(4)° γ=90.00°
Bis(2,3,5,6,8,9-hexahydro-1,4,7,10-benzotetraoxacyclododecin- 12-aminium) hexafluorosilicate dihydrate
2(C12H18NO4),F6Si,2(H2O)
Dalton transactions (Cambridge, England : 2003) (2007) 27 2915-2924
a=21.8548(6)Å b=8.0635(2)Å c=8.5300(2)Å
α=90.00° β=98.599(2)° γ=90.00°
Bis(1,4,7-trioxa-10-azoniacyclododecane) bis(aquapentafluorosilicate) trihydrate
2(C8H18NO3),2(F5H2O1Si1),2(H2O1),O1
Dalton transactions (Cambridge, England : 2003) (2007) 27 2915-2924
a=14.8889(7)Å b=9.3635(5)Å c=20.3291(9)Å
α=90.00° β=93.900(3)° γ=90.00°
Antimony trifluoride [1.5]dibenzothia-18-crown-6 clathrate
C20H24O5S,F3Sb
Acta Crystallographica Section E (2006) 62, 5 m1021-m1023
a=10.5980(2)Å b=16.2930(2)Å c=13.2860(2)Å
α=90.0000° β=111.3760(9)° γ=90.0000°
Cis-anti-cis dicyclohexyl-18-crown-6 bis(thiacetazone) bis methanol clathrate
C20H36O6,2C10H12N4OS,2CH4O
Acta Crystallographica Section E (2006) 62, 3 o911-o913
a=9.6712(18)Å b=9.9236(18)Å c=14.849(4)Å
α=93.17(3)° β=91.38(2)° γ=118.649(7)°
Rac-5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraaza- cyclotetradecane Hydrochloride Trihydrate
C16H38N4Cl23(H2O)
Acta Crystallographica Section C (1998) 54, 3 433-436
a=18.123(4)Å b=7.924(2)Å c=17.732(4)Å
α=90.00° β=111.11(3)° γ=90.00°
7,16-diazonia-18-crown-6-bis(4-aminobenzenesulfonate) dihydrate
C12H28N2O4,2C6H6NO3S,2H2O
Acta Crystallographica Section C (2003) 59, 2 o88-o90
a=12.319(2)Å b=10.976(2)Å c=22.826(4)Å
α=90° β=90° γ=90°
(H4-tet b) bis(hexafluorogermanate)tetrahydrate
C16H40N44,2F6Ge2,4H2O
Acta Crystallographica Section C (2003) 59, 5 m168-m170
a=9.5650(19)Å b=16.522(3)Å c=9.0210(18)Å
α=90.00° β=96.28(3)° γ=90.00°
Bis(2-carboxypyridinium) hexafluorosilicate
2C6H6NO2,F6Si2
Acta Crystallographica Section C (2007) 63, 9 o530-o534
a=9.3571(9)Å b=7.8717(6)Å c=9.8053(8)Å
α=90.00° β=91.943(7)° γ=90.00°
Bis(2-carboxyquinolinium) hexafluorosilicate dihydrate
2C10H8NO2,F6Si2,2H2O
Acta Crystallographica Section C (2007) 63, 9 o530-o534
a=6.6382(6)Å b=9.4274(9)Å c=17.0668(14)Å
α=90.00° β=91.731(8)° γ=90.00°
Bis(azonia-12-crown-4) bis(4-aminobenzoate) trihydrate
2C8H18NO3,2C7H6NO2,3H2O
Acta Crystallographica Section C (2006) 62, 1 o50-o52
a=12.541(3)Å b=9.5315(19)Å c=15.989(3)Å
α=90.00° β=110.91(3)° γ=90.00°
N,N'-Dibenzyl-4,13-diaza-18-crown-6
C26H38N2O4
Acta Crystallographica Section C (2005) 61, 3 o188-o192
a=16.993(3)Å b=22.455(5)Å c=13.391(3)Å
α=90.00° β=103.48(3)° γ=90.00°
N,N'-dibenzyl-1,4,10,13-tetraoxa-7,16-diazoniacyclooctadecane bis tetrafluoroborate monohydrate
C26H40N2O4,2BF4,H2O
Acta Crystallographica Section C (2005) 61, 3 o188-o192
a=7.9290(6)Å b=9.3870(6)Å c=11.6070(7)Å
α=69.342(4)° β=72.226(4)° γ=81.480(4)°
12-crown-4 bis(triphenylmethanethiol)
C8H16O4,2C19H16S
Acta Crystallographica Section C (2005) 61, 7 o431-o433
a=8.5960(10)Å b=9.8030(10)Å c=12.3530(10)Å
α=84.350(10)° β=89.180(10)° γ=73.610(10)°
4,10-diaza-1,7-diazoniacyclododecane bis(mefenamate) dihydrate
C8H22N4,2(C15H14NO2),2(H2O)
Crystal Growth & Design (2010) 10, 8 3647
a=32.809(4)Å b=7.6594(10)Å c=29.684(4)Å
α=90.00° β=104.457(2)° γ=90.00°
1,3-dihydroxy-2-(hydroxymethyl)propan-2-aminium mefenamate hydrate
C4H12NO3,C15H14NO2,H2O
Crystal Growth & Design (2010) 10, 8 3647
a=7.7773(16)Å b=8.4070(17)Å c=15.127(3)Å
α=90.642(4)° β=97.981(5)° γ=97.970(4)°
(5R,12S)-5,7,7,12,14,14-hexamethyl-4,11-diaza- 1,8-diazoniacyclotetradecane bis(mefenamate) dihydrate
C16H38N4,2(C15H14NO2),2(H2O)
Crystal Growth & Design (2010) 10, 8 3647
a=8.5654(14)Å b=8.7181(14)Å c=16.020(3)Å
α=102.383(3)° β=91.415(3)° γ=112.494(3)°
Piperazinediium bis(mefenamate) tetrahydrate
C4H12N2,2(C15H14NO2),4(H2O)
Crystal Growth & Design (2010) 10, 8 3647
a=6.9297(8)Å b=7.1741(8)Å c=18.621(2)Å
α=85.995(2)° β=83.245(2)° γ=65.812(2)°
Meso-5,7,7,12,12,14-hexamethyl-1,4,8,11- tetraaza- cyclotetradecane bis(salicylate)
C16H38N4,2(C7H5O3)
Crystal Growth & Design (2010) 10, 12 5210
a=7.7185(7)Å b=18.8796(17)Å c=10.3126(9)Å
α=90.00° β=92.642(2)° γ=90.00°
Azonia-12-crown-4 salicylate
C8H18NO3,C7H5O3
Crystal Growth & Design (2010) 10, 12 5210
a=12.0263(19)Å b=13.537(2)Å c=18.878(3)Å
α=90.00° β=90.447(3)° γ=90.00°
Azonia-18-crown-6 salicylate dihydrate
C12H26NO5,C7H5O3,2(H2O)
Crystal Growth & Design (2010) 10, 12 5210
a=27.132(2)Å b=10.2359(8)Å c=7.9185(6)Å
α=90.00° β=90.00° γ=90.00°
7,16-Diazonia-18-crown-6 bis(salicylate) trihydrate
C12H28N2O4,2(C7H5O3),3(H2O)
Crystal Growth & Design (2010) 10, 12 5210
a=9.434(2)Å b=12.587(3)Å c=13.843(2)Å
α=98.175(4)° β=90.721(2)° γ=111.355(3)°
Piperidinium salicylate
C5H12N,C7H5O3
Crystal Growth & Design (2010) 10, 12 5210
a=6.9819(6)Å b=18.7029(16)Å c=9.6814(8)Å
α=90.00° β=109.5739(15)° γ=90.00°
Cis-syn-cis (A) isomer (2,3,11,12-dicyclohexano- 1,4,7,10,13,16-hexaoxacyclooctadecane bis(ethanedithioamide) clathrate
C20H36O6,2(C2H4N2S2)
Organic & Biomolecular Chemistry (2003) 1, 16 2922
a=23.72000(10)Å b=7.6550(2)Å c=18.3640(3)Å
α=90.0000° β=106.9810(6)° γ=90.0000°
Benzazonia-15-crown-5 salicylate
C14H22NO4,C7H5O3
Crystal Growth & Design (2010) 10, 12 5210
a=5.4184(5)Å b=12.6000(12)Å c=15.9635(16)Å
α=112.789(2)° β=95.915(2)° γ=91.267(2)°